[ad_1]
Original title: iKang Guobin reported two Guosen Securities analysts in real name
Summary
[Il rapporto di ricerca accenna alla fusione di Ikang Guobin per riportare i due analisti di Guosen Securities in nome reale]Guosen Securities analysts never asked for verification or consultation with them during the report writing process and there was no merger or reorganization between them and Meinian Health Intent, these misleading statements will adversely affect the company’s normal operations . (West China Metropolis Daily)
IKang Guobin angry
Guosen SecuritiesAnalystWritingrelationshipDuring the process, they never asked for verification or consultation, and theyMeinian HealthThere is no merger eitherReorganizationIntention, these misleading statements willthe companyThe normal functioning of the company caused negative effects.
Guosen SecuritiesReply
Corporate securitiesAnalysts mentioned iKang Guobin in an audit report on listed companies, but the logic of the report itself is not to discuss the possibility of cooperation between related companies. It is possible that various parts have inconsistent interpretations of the individual expressions of the text, which has caused some misunderstandings.
Complaint for several daysGuosen SecuritiesLater, host iKang’s “anger” intensified. On November 12, iKang Guobin in his WeChatpublicIssue a document aChina Securities Regulatory CommissionReal-name report to two Guosen Securities analysts.
IKang Guobin said that Guosen Securities ahead of timeLimited Liability CompanySecurities ResearchteamAnalysts Xie Changyan and Zhu Hanqing did not follow the basic codes of practice of securities analysts and released listed companies that did not meet the requirements of relevant laws and regulationsresearch report, Hereby submit to the China Securities Regulatory CommissionmanagementCommittee, China Securities Regulatory Commission Shenzhen Supervision Bureau,China Securities Industry AssociationReport and complaint with real name.
However, Guosen Securities announced on November 13thto acceptWest China Metropolis Daily and Cover News responded in an interview that the Guosen Securities research report complies with laws and regulations. The mention of iKang Guobin in the report is not a discussion of the possibility of cooperation between related companies, and there is a misunderstanding.
Research reportWhich implies the merging of Ikang’s guestslawyerletter
On the evening of November 10, iKang Guobin released an “official statement on the false report of ‘Guosen Healthcare’ issued by the official WeChat account of ‘GuosenHealthcare'” on his official WeChat account.
The statement pointed out that on November 6, the WeChat public account “GuosenHealthcare” (the WeChat public account claimed to be the only subscription account managed by the Economic Research Institute of Guosen Securities Co., Ltd., and the copyright belongs to Guosen Securities Co., Ltd.) issued a report “Meinian Health: The accident happened for a reason, explore Alistrategy(Quick Commentary on Major Events) “, the report isOperatingThe status and development are analyzed and commented.
Ikang Guobin said the report indicated that Ikang Guobin had been affected by the outbreak.short termThis is not a good opportunity for asset injection, but it implies related parties have injected iKang Guobin as an asset in listed companiesMeinian HealthPotential agreements and plans.
In this regard, iKang Guobin said that Guosen Securities analysts never asked them to verify or consult them during the report writing process, and there is no intention to merge or reorganize between them and Meinian Health. These misleading statements will make the company The normal operation of the company has caused adverse effects.
At the same time, iKang Guobin also stated that he sent a lawyer’s letter to Guosen Securities on November 8. Ikang Guobin believes that the Guoxin Pharmaceutical report constitutes a misleading claim and that Ikang Guobin’s implicit intention, arrangement or plan to instill Meinian’s health has no concrete basis.
Guosen Securities responded to several interpretations and misunderstood
For the reasons for the report, Ikang Guobin provided three reasons.
Ikang Guobin believes that the content of the report prepared by Guosen Securities analysts constitutes a misleading statement and violates the relevant provisions of the Securities Act; Xie Changyan and Zhu Hanqing have not carefully verified the source of the information and data and are suspected of disseminating false, false and misleading information; Research reports issued by Guosen Securities analysts may be subject to interference and influence from interested parties.
Based on the above reasons, iKang Guobin filed the above reports and complaints with the real name and requested the Securities Regulatory Commission to investigate Xie Changyan and Zhu Hanqing.
A series of “offensives” for Ikang guests. On November 13, Guosen Securities responded in an interview with West China Metropolis Daily and Cover News stating that they have conducted the business of issuing securities research reports in accordance with laws and regulations. The company’s securities analyst mentioned Akcome in an audit report from a public company. State guest, but the logic of the relationship itself is not to discuss the possibility of collaboration between related companies.
Guosen Securities believes that the interpretation of the individual statements of the text may be inconsistent, which has caused some misunderstandings. We are currently actively contacting iKang state hosts to directly conductcommunicationAnd strive to eliminate related misunderstandings. In response to iKang Guobin’s complaints to securities regulators, we will also actively cooperate with relevant authorities. “works。
(Source: West China Metropolis Daily)
(Responsible publisher: DF524)
Solemnly declares: the purpose of this information is to disseminate more information, and it has nothing to do with this stand.
.
[ad_2]
Source link
